The South African government has opened a new centre to monitor the safety of antiretrovirals (ARVs) and other medicines used in the treatment of HIV and AIDS.
Health Minister Manto Tshabalala-Msimang said the centre would focus on the use of ARVs among adults, while a similar institution would monitor the impact of the drugs on children and pregnant women, according to Bua News, the government news agency.
"The risk and toxicity profile of antiretrovirals needs to be understood in the South African setting, and the complexities associated with various regimens should be continually assessed," Tshabalala-Msimang said.
The new centre, based at the Medical University of South Africa in Ga-Rankuwa outside Pretoria, is due to be fully operational in October.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions
Right now, we’re working with contributors on the ground in Ukraine and in neighbouring countries to tell the stories of people enduring and responding to a rapidly evolving humanitarian crisis.
We’re documenting the threats to humanitarian response in the country and providing a platform for those bearing the brunt of the invasion. Our goal is to bring you the truth at a time when disinformation is rampant.
But while much of the world’s focus may be on Ukraine, we are continuing our reporting on myriad other humanitarian disasters – from Haiti to the Sahel to Afghanistan to Myanmar. We’ve been covering humanitarian crises for more than 25 years, and our journalism has always been free, accessible for all, and – most importantly – balanced.
You can support our journalism from just $5 a month, and every contribution will go towards our mission.